Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:864-868
Published online before print February 3, 2003, doi: 10.1161/01.CIR.0000049744.23613.69
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/6/864    most recent
01.CIR.0000049744.23613.69v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitsnefes, M. M.
Right arrow Articles by Daniels, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitsnefes, M. M.
Right arrow Articles by Daniels, S. R.
Related Collections
Right arrow Hypertrophy
Right arrow Myocardial cardiomyopathy disease
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2003;107:864.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Left Ventricular Mass and Systolic Performance in Pediatric Patients With Chronic Renal Failure

Mark M. Mitsnefes, MD; Thomas R. Kimball, MD; Sandra A. Witt, RDCS; Betty J. Glascock, RDCS; Philip R. Khoury, MS; Stephen R. Daniels, MD, PhD

From the Divisions of Nephrology and Hypertension (M.M.M.) and Cardiology (T.R.K., S.A.W., B.J.G., P.R.K., S.R.D.), Cincinnati Children’s Hospital Research Foundation, Cincinnati, Ohio.

Correspondence to Mark M. Mitsnefes, MD, Division of Nephrology and Hypertension, MLC: 7022, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229-3039. E-mail mark.mitsnefes{at}CCHMC.org


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— Children with chronic renal disease have a high prevalence of left ventricular hypertrophy (LVH), which is thought to be adaptive to improve contractility and lower wall stress in the face of increased afterload and preload. The aim of this study was to determine the association between LV mass, LV performance, and LV contractility in children with chronic renal insufficiency (CRI) and children undergoing chronic dialysis.

Methods and Results— Twenty-five children with CRI, 12 undergoing chronic dialysis, and 24 controls had echocardiographic evaluation during rest and peak exercise. LV performance was assessed by calculation of shortening fraction and heart rate–corrected velocity of circumferential fiber shortening (VCF). Contractility (VCF difference) was determined based on the relation between VCF and end-systolic wall stress. Contractile reserve was assessed by the difference between contractility at rest and peak exercise. The dialysis group had higher LVM index than the group with CRI (42.9±10.3 versus 29.9±9.4 g/m2.7, P<0.001). Both groups had higher LVM index compared with controls (22.2±6.1 g/m2.7, P<0.001). At rest, the CRI and dialysis groups had significantly higher VCFc (P<0.001) and VCF difference (P<0.05) and significantly lower wall stress (P<0.01) compared with the control group. Dialysis patients had significantly lower contractile reserve compared with the control group (P<0.03).

Conclusions— These results indicate that children with CRI and undergoing chronic dialysis have increased LVM, LV performance, and contractility at rest. However, dialysis patients have diminished contractile reserve during exercise, which might be an indicator for the development of more severe systolic dysfunction over time.


Key Words: pediatrics • kidney • cardiovascular diseases • hypertrophy • contractility


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cardiac complications are frequent in children with chronic renal disease. Echocardiographic studies show that young patients with chronic renal insufficiency (CRI) and end-stage renal disease have abnormalities of both left ventricular (LV) structure and function.15 Children with chronic renal disease have a high prevalence of left ventricular hypertrophy (LVH).1,610 In adults with hypertension and chronic renal failure, LVH is thought to be initially adaptive to improve contractility and lower wall stress (WS) in the face of increased afterload (blood pressure) and preload (volume).1113 However, in adults, progression of renal failure frequently leads to systolic dysfunction, which is associated with clinical signs of cardiac failure and decreased survival.3 In contrast, systolic LV function is thought to be preserved in children with chronic renal failure.1,4,5 However, these studies have examined LV systolic performance at rest, and it is possible that evaluation during exercise may unmask more subtle changes in LV function.

The aims of this study were to evaluate cardiac structure, evaluate LV systolic performance at rest and during exercise, and determine the association between LV mass, LV performance, and contractility in children with CRI and undergoing chronic dialysis. We hypothesized that resting LV systolic performance would be normal and related to the presence of LVH. We also hypothesized that children with advanced chronic renal failure and LVH would have decreased LV functional reserve during exercise.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subjects
The study population included 25 patients with CRI, 12 children undergoing chronic dialysis, and 24 healthy individuals of comparable age and sex. Inclusion criteria were age 6 to 20 years, measured glomerular filtration rate 20 to 75 mL/min per 1.73 m2 for CRI patients, at least 6 weeks of chronic dialysis for dialysis patients, absence of congenital, structural, or primary myocardial disease, and good-quality echocardiographic images. The Institutional Review Board of Cincinnati Children’s Hospital Medical Center approved the study, and informed consent was obtained for each study patient.

The medical records were reviewed for age, sex, race, type of dialysis modality, cause of chronic renal disease, and duration of renal failure. All patients had a history and physical examination. Clinical and laboratory data were collected on the day of the echocardiographic evaluation (before dialysis in heart disease patients), including height, weight, heart rate, systolic blood pressure (SBP), diastolic blood pressure (DBP), serum creatinine, and hemoglobin. The mean of monthly blood pressure measurements for 6 months preceding the echocardiogram was calculated for CRI and dialysis patients. To control for differences in age, blood pressures were indexed to the age-, sex-, and height-specific 95th percentile for each subject (calculated mean SBP or DBP was divided by the age-, sex-, and height-specific 95th percentiles SBP or DBP). Hypertension was defined as SBP, DBP, or both >95th percentile for sex, age, and height or indexed SBP or DBP >1.0. The kidney function for CRI patients was estimated by measuring glomerular filtration rate (GFR) using a single intravenous injection of Ioversol injection 74% (Optiray 350, Mallinckrodt Inc).14 Iodine in timed blood samples was measured by x-ray fluorescence analysis (Renalyzer PRX90, Diatron AB Inc), and GFR was calculated from the slope of the iodine disappearance curve.

Echocardiography
Each patient had echocardiographic evaluation during rest and exercise. Echocardiograms were performed using standard techniques. LV mass (LVM) was measured by two-dimensional directed M-mode echocardiography at rest according to the American Society of Echocardiography criteria.15 LVM index (mass divided by height raised to a power of 2.7 [g/m2.7]) was used to evaluate LVH accounting for body size, as described elsewhere.16 LVH was defined as LVM index >95th percentile for healthy children and adolescents.17 Resting LV performance was assessed by calculation of shortening fraction (SF) and heart rate–corrected velocity of circumferential fiber shortening (VCF). A load-independent index of contractility was determined based on the relation between VCF and end-systolic wall stress (WS) by calculation of the difference between measured and predicted velocity of circumferential fiber shortening (VCFdif) for the calculated WS.18 Left ventricular end-diastolic dimension (LVEDD) indexed by body surface area raised to the 0.5 power was used as an estimate of LV preload.19 End-systolic WS and indexed SBP and DBP were used to estimate LV afterload.

Exercise Test
Study subjects underwent a recumbent ergometer (KHL Model 8450) maximal exercise test using the James Protocol.20 Heart rate and a 6-lead rhythm strip were recorded at rest, during each minute of exercise, immediately after exercise, and 1, 3, 5, 10, and 15 minutes after exercise (Marquette Model Case 16). Blood pressure was measured at rest, 2 minutes into each workload, immediately after exercise, and 1, 3, 5, 10, and 15 minutes after exercise using the auscultation method and a manual sphygmomanometer with a cuff appropriately sized for the patient. SF, VCF, and WS were assessed by echocardiography immediately before and after exercise. Contractile reserve reflects the ability of the heart to respond to stress and was assessed by the difference between contractility at rest and peak exercise.

Statistical Analysis
Values are presented as mean±SD. A 2-sample t test was used to compare mean±SD of continuous variables. The general, linear model procedure was used to compare mean±SD among all 3 groups. Categorical variables were compared using the {chi}2 test or Fisher’s exact test. The associations between variables were assessed by Pearson correlation analysis. P<=0.05 was considered statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Patient Characteristics
The main demographic and clinical characteristics are presented in Table 1. Children with CRI and undergoing dialysis were smaller than control subjects. Nine of 12 dialysis patients were black, whereas 4 (16%) of 25 CRI patients and 4 (17%) of 24 controls were black. There were more boys in the control (62%) and CRI (71%) groups, whereas the dialysis group had more girls (60%). Eight (67%) of 12 dialysis patients and 6 (24%) of 25 CRI patients were hypertensive. In the dialysis group, 3 patients were receiving peritoneal dialysis and 9 patients were receiving hemodialysis. Hemodialysis access was by arteriovenous (a-v) graft (6 patients) or permanent right atrial catheter (3 patients). All 12 dialysis patients were taking antihypertensive medications; 9 patients were taking 1 medication, 2 patients were taking 2 medications, and 1 patient was taking 3 medications. Antihypertensive medications prescribed included calcium-channel blockers (10 patients), ß-blockers (1 patient), and ACE inhibitors (3 patients). Eight of 25 (32%) children with CRI were taking antihypertensive medications (all patients with CRI were taking only ACE inhibitors). The main causes of chronic renal disease in children with CRI were renal dysplasias/obstructive uropathies (63%) and glomerular and cystic diseases (37%). In dialysis patients, the main cause of end-stage renal disease was glomerular disease (70%), whereas congenital anomalies represented 30%. No difference in the mean hemoglobin level was seen between patients with CRI and those undergoing dialysis (hemoglobin was not measured in control patients). The mean GFR for children with CRI was 39.3±12.5 mL/min per 1.73 m2, 7 (28%) patients had mild CRI with GFR 50 to 75 mL/min per 1.73 m2, and 18 (72%) patients had moderate CRI with GFR 25 to 49 mL/min per 1.73 m2.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Patients’ Characteristics

Left Ventricular Mass
Both children with CRI (29.3±6.7 g/m2.7) and children undergoing dialysis (44.9±15.9 g/m2.7) had elevated LVM index compared with the control group (22.2±6.1 g/m2.7, P<0.001) (Figure). Children undergoing chronic dialysis had significantly higher LVM index compared with patients with CRI (P<0.001). Seven (58%) of 12 dialysis patients and 6 (24%) of 25 children with CRI had LVH. There was no significant difference in LVM index in children with mild or moderate CRI, nor was there a difference between those taking and not taking blood pressure medications in this group of patients.



View larger version (16K):
[in this window]
[in a new window]
 
Mean±SD of LVM indexes for 3 groups of patients. P is the overall difference among 3 groups, as determined by GLM procedure.

In children with CRI, LVM index was not significantly related to indexed SBP, DBP (measures of afterload), or LVEDD (a measure of preload or volume status). In contrast, in dialysis patients, LVM index was positively correlated with indexed SBP (r=0.74, P=0.01) and DBP (r=0.85, P=0.001) and indexed LVEDD (r=0.72, P=0.02)

Hemodynamic Data at Rest
Patients with CRI had significantly higher heart rate, SF, VCF, and VCFdif and significantly lower WS compared with controls (Table 2). Dialysis patients had significantly higher heart rate, VCF, VCFdif, indexed SBP, and DBP and significantly lower WS compared with controls. Despite the significantly higher LVM index in patients with CRI compared with those undergoing dialysis, there was no significant difference in WS, VCF, indexed SBP, and VCFdif for these two groups of patients.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Hemodynamic Data at Rest

Exercise Echocardiographic Data
All control subjects, 18 of 25 CRI children, and all dialysis patients completed exercise stress echocardiography and were included in the analysis. Children with CRI and undergoing dialysis had significantly less increase in SBP (P<0.001) during exercise compared with controls (Table 3). Children undergoing chronic dialysis had significantly less increase in heart rate than the control group and children with CRI (P<0.001). Children with CRI and those undergoing dialysis had significantly less decrease in WS (P<0.01) compared with controls. Children undergoing chronic dialysis had significantly less increase in VCF (P=0.03) and SF (P=0.02) compared with the control group. Contractile reserve was similar for controls and patients with CRI. Contractile reserve was significantly lower in patients undergoing dialysis compared with the control group (P<0.03). Contractile reserve was also lower in dialysis group compared with CRI patients, but the difference did not reach statistical significance (P=0.11).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Hemodynamic Data During Stress Echocardiography


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The important observations of this study are that both children with CRI and children undergoing chronic dialysis have increased LVM, LV performance, and contractility at rest. In addition, dialysis patients have diminished contractile reserve during exercise. These findings indicate that important cardiac abnormalities are present in children with CRI and chronic dialysis.

Mechanisms of Increased LVM in Children With Chronic Renal Disease
There are many factors contributing to the development of cardiac hypertrophy in adults with chronic renal failure. Most authors agree that LVH in these patients develops as a response to chronic volume and pressure overload. For example, Levin et al21,22 showed that anemia and hypertension were independent predictors for increased LVM in the predialysis period in adults. In the only pediatric study of patients with CRI, Johnstone et al1 performed a cross-sectional analysis of 32 children (age 1.5 to 16.9 years) and found that 22% had LVH. In their study, serum creatinine level was the only independent predictor of LVM index. In our study, a similar prevalence of LVH (24%) was found in patients with CRI. We found no relationship between LVM index, creatinine concentration (or GFR), and indexed blood pressure in these children. Small sample size might contribute to these results. Future studies of pediatric patients with CRI should rely on ambulatory blood pressure monitoring as a method of choice for assessing the relationship between LVM and blood pressure. Some data suggest that mean 24-hour blood pressure is a better predictor of increased LVM than office blood pressure in adults with CRI.23 In contrast to the CRI group, we were able to show strong relationships of both LVEDD (preload) and indexed SBP or DBP (afterload) to LVM index in the group undergoing dialysis. These results are not surprising, because most of the dialysis children were hypertensive and were undergoing chronic hemodialysis, with two thirds of them having a-v shunting as a result of their graft. This suggests that, as in adults with end-stage renal disease, the mechanism of LVH in our chronic dialysis patients is most likely attributable to both volume and pressure overload.

Mechanisms of Increased LV Performance in Children With Chronic Renal Disease
Most previous studies have examined LV systolic performance using indexes of performance dependent on loading conditions. This presents a major problem for patients with CRI or undergoing dialysis, because they may have substantial alteration of preload and afterload. Few studies have investigated load-independent contractility at rest or during exercise in children with chronic renal failure. The study by Colan et al4 emphasizes the importance of taking loading conditions into account. They determined that 55% of children and young adults immediately at the onset of dialysis had abnormal ejection phase indexes of LV systolic function at rest. However, this was likely to be attributable to abnormal preload or afterload, because a load-independent measure of contractility was normal in all subjects.

Increased systolic performance at rest in our patients with CRI is most likely attributable to a low LV afterload, as demonstrated by a low LV end-systolic WS and elevated contractility, as exhibited by increased VCF difference. It is likely that low end-systolic WS is attributable to increased LVM in patients with CRI. The reason for increased LV contractility in these children is not clear. It is possible that in a state of developing renal failure, elevated contractility is an adaptive mechanism needed to increase cardiac output and improve renal perfusion because of higher metabolic demands. Increased sympathetic activity is thought to contribute to this process.24,25 This might also explain the increased resting heart rate in our patients. Because the indices used to measure function were either independent of heart rate or corrected for heart rate (eg, VCFc), we believe that the difference noted between groups was unlikely attributable to heart rate difference.

One potential mechanism for the hyperdynamic circulation in dialysis patients is increased cardiac workload secondary to the effect of anemia, a-v shunt, and poorly controlled hypervolemia. However, after controlling for loading conditions (preload and afterload), these children continued to demonstrate increased VCF difference, suggesting that the increase in LV performance is attributable to increased contractility.

Despite the fact that dialysis patients had significantly higher LVM index than patients with CRI, both renal groups had similar LV performance and contractility at rest. However, there was a different response to exercise in these patients. Children with CRI had cardiac reserve similar to healthy controls, as demonstrated by the difference in LV contractility between rest and peak exercise data during stress echocardiography. These results suggest that children with mild to moderate renal failure have a physiological response to exercise, which is associated with increased in LV performance attributable to increased contractility and decreased afterload.26 In contrast, we found that in patients undergoing dialysis, contractile reserve was blunted compared with control and CRI patients. Thus, patients undergoing dialysis may rely on increased LVM to produce normal LV performance at rest. However, this comes at the expense of a blunted response to exercise. These results are concordant with adult studies. For example, Fontanet et al27 showed that hypertensive adults with LVH had limited myocardial contractile reserve during dobutamine stress echocardiography. These results may explain why many subjects undergoing chronic dialysis in our study developed exercise fatigue during early stages of the test. Our findings suggest that children undergoing chronic dialysis with increased LVM may not have normal cardiac function and might be at risk of future development of systolic dysfunction and heart failure.

One of the potential mechanisms affecting LV function is the use of ACE inhibitors, because these medications are known to be beneficial to cardiac function and structure. In our study, there was no significant difference in the use of ACE inhibitors in children with CRI (32%) or dialysis patients (25%), making it unlikely that ACE inhibitors accounted for the difference in LVM or LV contractile reserve between the two renal groups. These results should be interpreted with caution because of the small sample size in our study. Larger prospective studies are necessary to evaluate the effect of ACE inhibitors on cardiac structure and function in children with chronic renal failure.

In summary, we demonstrated that children and adolescents with chronic renal failure develop LVH and increased LV performance, which may be an adaptive process in response to increased blood pressure and higher metabolic demands seen in these patients. However, when the cardiovascular system is stressed by exercise, this compensation may be insufficient in children undergoing chronic dialysis. Thus, diminished contractile reserve in these children might reflect the early development of a maladaptive stage of LVH with risk of ultimate worsening of cardiac function and development of congestive heart failure over time.


*    Acknowledgments
 
This research was supported by grants 2K12HD28827 and K23 HL69296-01A1 from the National Institutes of Health.

Received August 6, 2002; revision received November 4, 2002; accepted November 4, 2002.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Johnstone LM, Jones CL, Grigg LE, et al. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int. 1996; 50: 998–1006.[Medline] [Order article via Infotrieve]

2. Goren A, Glaser J, Drukker A. Diastolic function in children and adolescents on dialysis and after kidney transplantation: an echocardiographic assessment. Pediatr Nephrol. 1993; 7: 725–728.[CrossRef][Medline] [Order article via Infotrieve]

3. Parfrey PS, Foley RN, Harnett JD, et al. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 1996; 11: 1328–1331.[Free Full Text]

4. Colan SD, Sanders SP, Ingelfinger JR, et al. Left ventricular mechanics and contractile state in children and adolescents with end-stage renal disease: effect of dialysis and renal transplantation. J Am Coll Cardiol. 1987; 10: 1085–1094.[Abstract]

5. Palcoux JB, Palcoux MC, Jouan JM, et al. Echocardiographic patterns in infants and children with chronic renal failure. Int J Pediatr Nephrol. 1982; 3: 311–314.[Medline] [Order article via Infotrieve]

6. O’Regan S, Matina D, Ducharme G, et al. Echocardiographic assessment of cardiac function in children with chronic renal failure. Kidney Int. 1983; 15 (suppl): 77–82.

7. Drukker A, Urbach J, Glaser J. Hypertrophic cardiomyopathy in children with end-stage renal disease and hypertension. Proc Eur Transplant Assoc. 1981; 18: 542–547.

8. Loirat C, Ehrich JHH, Geerlings W, et al. Report on management of renal failure in children in Europe, XXIII. Nephrol Dial Transplant. 1994; 9 (suppl 1): 26–40.

9. Morris KP, Skinner JR, Wren C, et al. Cardiac abnormalities in end stage renal failure and anaemia. Arch Dis Child. 1993; 68: 637–643.[Abstract/Free Full Text]

10. Mitsnefes MM, Daniels SR, Schwartz SM, et al. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000; 14: 898–902.[CrossRef][Medline] [Order article via Infotrieve]

11. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human ventricle. J Clin Invest. 1975; 56: 56–64.[Medline] [Order article via Infotrieve]

12. Ganau A, Devereux RB, Pickering TG, et al. Relationship o left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 1990; 81: 25–36.[Abstract/Free Full Text]

13. Dahan M, Siohan P, Viron B, et al. Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: an echocardiographic study. Am J Kidney Dis. 1997; 30: 780–785.[CrossRef][Medline] [Order article via Infotrieve]

14. Stake G, Monclair T. A single plasma sample method for estimation of the glomerular filtration rate in infants and children using iohexol, I: establishment of a body weight-related formula for the distribution volume of iohexol. Scand J Clin Lab Invest. 1991; 51: 335–342.[Medline] [Order article via Infotrieve]

15. Devereux RB, Reichec N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977; 55: 613–618.[Abstract/Free Full Text]

16. De Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992; 20: 1251–1260.[Abstract]

17. De Simone G, Devereux RB, Daniels SR, et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995; 25: 1056–1062.[Abstract]

18. Colan SD, Borow KM, Neuman A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load independent index of myocardial contractility. J Am Coll Cardiol. 1984; 4: 715–724.[Abstract]

19. Gutgesell HP, Rembold CM. Growth of the human heart relative to body surface area. Am J Cardiol. 1990; 65: 662–668.[CrossRef][Medline] [Order article via Infotrieve]

20. James FW, Kaplan S, Glueck CJ, et al. Responses of normal children and young adults to controlled bicycle exercise. Circulation. 1980; 6: 902–912.

21. Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996; 27: 347–354.[Medline] [Order article via Infotrieve]

22. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999; 34: 125–134.[Medline] [Order article via Infotrieve]

23. Tucker B, Fabbian F, Giles M, et al. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant. 1997; 12: 724–728.[Abstract/Free Full Text]

24. Converse RL Jr, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992; 327: 1912–1918.[Abstract]

25. Metivier F, Marchais SJ, Guerin AP, et al. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000; 15 (suppl 3): 14–18.[Abstract/Free Full Text]

26. Poliner LR, Dehmer GJ, Lewis SE, et al. Left ventricular performance in normal subjects: a comparison of the responses to exercise in the upright and supine positions. Circulation. 1980; 62: 528–534.[Free Full Text]

27. Fontanet HL, Perez JE, Davila-Roman. Diminished contractile reserve in patients with left ventricular hypertrophy and increased end-systolic stress during dobutamine stress echocardiography. Am J Cardiol. 1996; 78: 1029–1035.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C. Rinat, R. Becker-Cohen, A. Nir, S. Feinstein, D. Shemesh, N. Algur, E. Ben Shalom, B. Farber, and Y. Frishberg
A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure
Nephrol. Dial. Transplant., November 23, 2009; (2009) gfp570v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. D. J. Ten Harkel, K. Cransberg, M. Van Osch-Gevers, and J. Nauta
Diastolic dysfunction in paediatric patients on peritoneal dialysis and after renal transplantation
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1987 - 1991.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. J. Foster, A. S. Mackie, M. Mitsnefes, H. Ali, S. Mamber, and S. D. Colan
A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in Children
Circulation, May 27, 2008; 117(21): 2769 - 2775.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. J. Weaver Jr., T. R. Kimball, T. Knilans, W. Mays, S. K. Knecht, Y. M. Gerdes, S. Witt, B. J. Glascock, J. Kartal, P. Khoury, et al.
Decreased Maximal Aerobic Capacity in Pediatric Chronic Kidney Disease
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. L. McNiece, M. Gupta-Malhotra, J. Samuels, C. Bell, K. Garcia, T. Poffenbarger, J. M. Sorof, and R. J. Portman
Left Ventricular Hypertrophy in Hypertensive Adolescents: Analysis of Risk by 2004 National High Blood Pressure Education Program Working Group Staging Criteria
Hypertension, August 1, 2007; 50(2): 392 - 395.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Circulation, December 12, 2006; 114(24): 2710 - 2738.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Covic, N. Mardare, P. Gusbeth-Tatomir, O. Brumaru, C. Gavrilovici, M. Munteanu, O. Prisada, and D. J. A. Goldsmith
Increased arterial stiffness in children on haemodialysis
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 729 - 735.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. C. Matteucci, E. Wuhl, S. Picca, A. Mastrostefano, G. Rinelli, C. Romano, G. Rizzoni, O. Mehls, G. de Simone, F. Schaefer, et al.
Left Ventricular Geometry in Children with Mild to Moderate Chronic Renal Insufficiency
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 218 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. M. Mitsnefes, T. R. Kimball, J. Kartal, S. A. Witt, B. J. Glascock, P. R. Khoury, and S. R. Daniels
Cardiac and Vascular Adaptation in Pediatric Patients with Chronic Kidney Disease: Role of Calcium-Phosphorus Metabolism
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2796 - 2803.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. D. Hanevold, P.-L. Ho, L. Talley, and M. M. Mitsnefes
Obesity and Renal Transplant Outcome: A Report of the North American Pediatric Renal Transplant Cooperative Study
Pediatrics, February 1, 2005; 115(2): 352 - 356.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
National High Blood Pressure Education Program Wor
The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents
Pediatrics, August 1, 2004; 114(2/S2): 555 - 576.
[Full Text] [PDF]


Home page
CirculationHome page
M. M. Mitsnefes, T. R. Kimball, S. A. Witt, B. J. Glascock, P. R. Khoury, and S. R. Daniels
Abnormal Carotid Artery Structure and Function in Children and Adolescents With Successful Renal Transplantation
Circulation, July 6, 2004; 110(1): 97 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Zoccali, F. A. Benedetto, F. Mallamaci, G. Tripepi, G. Giacone, A. Cataliotti, G. Seminara, B. Stancanelli, and L. S. Malatino
Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis Patients
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1029 - 1037.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/6/864    most recent
01.CIR.0000049744.23613.69v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitsnefes, M. M.
Right arrow Articles by Daniels, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitsnefes, M. M.
Right arrow Articles by Daniels, S. R.
Related Collections
Right arrow Hypertrophy
Right arrow Myocardial cardiomyopathy disease
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery